Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
4DMedical Ltd (AU:4DX)
ASX:4DX
Holding AU:4DX?
Track your performance easily
4DX Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.41 - AU$1.10
Previous CloseAU$0.41
Volume142.37K
Average Volume (3M)441.81K
Market Cap
AU$168.32M
Enterprise ValueAU$123.44M
Total Cash (Recent Filing)AU$51.11M
Total Debt (Recent Filing)AU$6.24M
Price to Earnings (P/E)―
Beta0.89
Next Earnings
Feb 25, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares OutstandingN/A
10 Day Avg. Volume267,767
30 Day Avg. Volume441,809
Standard Deviation0.33
R-Squared0.05
Alpha-0.00369
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)190.51
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$1.05Price Target Upside138.64% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
4DMedical Ltd News
PremiumCompany Announcements
4DMedical Posts Strong Growth and Strategic ExpansionsPremiumCompany Announcements
4DMedical Ltd: Revenue Up Despite Losses
PremiumCompany Announcements
4DMedical Announces Expiry of Stock Options
PremiumCompany Announcements
4DMedical Limited Expands Share Offerings
PremiumCompany Announcements
4DMedical Reports Soaring Revenue and Strategic Growth
PremiumCompany Announcements
4DMedical to Quote New Shares on ASX
PremiumCompany Announcements
4DMedical Secures Deal to Boost Lung Imaging
PremiumCompany Announcements
4DMedical Issues Shares and Expands TechnologyOptions Prices
Currently, No data available
---
Ownership Overview
17.25% Insiders
0.00% Mutual Funds
<0.01% Other Institutional Investors
82.75% Public Companies and
Individual Investors
4DX FAQ
What was 4DMedical Ltd’s price range in the past 12 months?
4DMedical Ltd lowest share price was AU$0.41 and its highest was AU$1.10 in the past 12 months.
What is 4DMedical Ltd’s market cap?
Currently, no data Available
When is 4DMedical Ltd’s upcoming earnings report date?
4DMedical Ltd’s upcoming earnings report date is Feb 25, 2025 which is in 159 days.
How were 4DMedical Ltd’s earnings last quarter?
4DMedical Ltd released its earnings results on Aug 29, 2024. The company reported -AU$0.068 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.068.
Is 4DMedical Ltd overvalued?
According to Wall Street analysts 4DMedical Ltd’s price is currently Undervalued.
Does 4DMedical Ltd pay dividends?
4DMedical Ltd does not currently pay dividends.
What is 4DMedical Ltd’s EPS estimate?
4DMedical Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does 4DMedical Ltd have?
4DMedical Ltd has 410,531,160 shares outstanding.
What happened to 4DMedical Ltd’s price movement after its last earnings report?
4DMedical Ltd reported an EPS of -AU$0.068 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.762%.
Which hedge fund is a major shareholder of 4DMedical Ltd?
Currently, no hedge funds are holding shares in AU:4DX
---
4DMedical Ltd Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$1.05 (138.64% Upside)
AU$1.05 (138.64% Upside)
Blogger Sentiment
Bullish
AU:4DX Sentiment 93%
Sector Average 70%
Sector Average 70%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-32.23%
12-Months-Change
Fundamentals
Return on Equity
-50.54%
Trailing 12-Months
Asset Growth
29.15%
Trailing 12-Months
Company Description
4DMedical Ltd
4DMedical Ltd is a company whose principal activities is medical research technology and the development of a non?invasive respiratory imaging solution using four?dimensional imaging. The four-dimensional lung imaging technology utilises mathematics models and algorithms to convert X-ray scans into quantitative data which helps the physicians to manage patients with respiratory diseases and diseases of the lung.
---
4DX Stock 12 Month Forecast
Average Price Target
AU$1.05
▲(138.64% Upside)
Technical Analysis
Medical Developments International Limited
―
Resonance Health Ltd
―
Cyclopharm Limited
―
PainChek Ltd
―
Best Analysts Covering 4DX
1 Year
1 Year Success Rate
3/6 ratings generated profit
1 Year Average Return
+0.85%
reiterated a buy rating 7 months ago
Copying John Hester's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +0.85% per trade.
---